Corticosteroids in severe sepsis

Clinical Pulmonary Medicine

Volumn 8, Issue 5, 2001, Pages 273-278

  Annane, Djillali ^a   Bollaert, Pierre Edouard ^b   Lagente, Vincent ^c   Bellissant, Eric ^c  

^a RAYMOND POINCARÉ HOSPITAL   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c UNIVERSITÉ DE RENNES 1   (France)

Author keywords

Animal studies; Clinical pharmacology; Clinical trials; Corticosteroids; Severe sepsis

Indexed keywords

CORTICOSTEROID; HYDROCORTISONE;

ANTIINFLAMMATORY ACTIVITY; CAUSE OF DEATH; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HORMONE ACTION; HUMAN; IMMUNE RESPONSE; INTENSIVE CARE UNIT; MORBIDITY; REVIEW; SEPSIS; SEPTIC SHOCK; SURVIVAL;

EID: 0034803834     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045413-200109000-00003     Document Type: Review

References (54)

1. Annual summary of births, marriages, divorces and deaths, 1993
2. Treating patients with severe sepsis
3. The clinical significance of positive blood cultures: A comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis
4. Suprarenal cortical hormone and salt in the treatment of pneumonia and other severe infections
5. Clinical trial design in studies of corticosteroids for bacterial infections
6. Steroid controversy in sepsis and septic shock: A meta-analysis
7. Corticosteroid treatment for sepsis: A critical appraisal and meta-analysis of the literature
8. Reduction of mortality in chloramphenicol-treated severe typhoid fever by high-dose dexamethasone
9. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A double-blind, placebo-controlled trial
10. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis
11. Reversal of late septic shock with supraphysiologic doses of hydrocortisone
12. Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study
13. Effects of hydrocortisone on the immune response in patients with septic shock-results from a double-blind cross-over study
14. Hydrocortisone reverses refractory septic shock
15. Molecular mechanisms of action of steroid/thyroid receptor superfamily members
16. Biological and clinical aspects of interleukin 6
17. Negative regulation by glucocorticoids through interference with a cAMP responsive enhancer
18. Transcription factor interactions: Selectors of positive or negative regulation from a single DNA element
19. Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor
20. Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-κ B is target for glucocorticoid-mediated interleukin 8 gene repression
21. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids
22. Immunosuppression by glucocorticoids: Inhibition of NF-KB activity through induction of IκB synthesis
23. Dexamethasone inhibits the induction of monocyte chemostatic-activating factor production by IL-1 or tumor necrosis factor
24. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation
25. Modulation of IL-1induced neutrophil migration by dexamethasone and lipocortin 1
26. Corticosteroids suppress cyclooxygenase messenger RNA levels and prostanoid synthesis in cultured vascular cells
27. Effects of topical corticosteroids on inflammatory mediator-induced eicosanoid release by human airway epithelial cells
28. Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages
29. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells
30. Studies on the mechanism of hydrocortisone potentiation of vasoconstrictor responses to epinephrine in the anesthetized animal
31. Glucocorticoids modulate vascular reactivity in the rat
32. Doseresponse relationships and mineralocorticoid activity in cortisol-induced hypertension in humans
33. Cortisol and hypertension
34. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo
35. Effect of dexamethasone on the onset and persistence of vascular hyporeactivity induced by E. coli lipopolysaccharide in rats
36. Stimulation of the phosphoinositide signaling system as a possible mechanism for glucocorticoid action in blood pressure control
37. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man
38. Influence of hypercortisolemia on soluble tumor necrosis factor receptor II and interleukin-1 receptor antagonist responses to endotoxin in human beings
39. Hypercortisolemia increases plasma interleukin-10 concentrations during human endotoxemia - A clinical research center study
40. Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome. The phospholipase A2 study group
41. Local venous responses to endotoxin in humans
42. Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve
43. Effect of hydrocortisone on phenylephrine-mean arterial pressure dose-response relationship in septic shock
44. The cardiopulmonary response to massive doses of steroids in patients with septic shock
45. The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study
46. Corticosteroid/antibiotic treatment of adrenalectomized dogs challenged with lethal E. coli
47. Steroid therapy in septic shock. Survival studies in a laboratory model
48. Case of suprarenal apoplexy
49. Nebennierenapoplexie bei kleinen kindern
50. Cortisol response to corticotropin and survival in septic shock
51. Adrenal insufficiency occurring during septic shock: Incidence, outcome, and relationship to peripheral cytokine levels
52. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin
53. Steroids in the treatment of clinical septic shock
54. Cortisol replacement in severely stressed patients